INmune Bio to Participate in Baird's Biotech Discovery Series Webcast on February 13, 2024 Seite 1

06.02.2024 - Boca Raton, Florida, Feb. 06, 2024 (GLOBE NEWSWIRE) -  INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company targeting microglial activation and neuroinflammation as a cause of Alzheimer’s disease (AD) with XProTM ... Seite 1

Related Keywords

University Of Florida ,Florida ,United States ,Boca Raton ,Malu Tansey ,Susan Fixel ,Nasdaq ,Inmune Bio Inc ,Parkinson Foundation Research Center ,Biotech Discovery Series ,Susan Fixel Chair ,Foundation Research Center ,White Matter Free Water ,Inmune Bio Chart ,Nmune Bio Kurs ,Inmune Bio Aktie ,